News

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional ...
FDA appears to be slow-walking vaccine approvals
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
FOX 13 Utah7m
170K bottles of apple juice recalled due to potential toxin contamination
Approximately 170,000 bottles of Martinelli's apple juice have been recalled due to potential patulin contamination. Here's ...
A Federal Judge Greenlights a Lawsuit That Claims Florida's Ban on Lab-Grown Meat Is Unconstitutional
U.S. District Judge Mark Walker says Upside Foods has plausibly alleged that the law's protectionism violates the "dormant" ...
Bugs, beets play role in eliminating artificial dyes
As pressure grows to get artificial colors out of the U.S. food supply, scientists are exploring natural sources such as beet ...
The Dominion Post53m
Mon EMS rolling out state’s third whole blood program
It’s just a matter of time. Barring other complications, a patient suffering a severe hemorrhage has about 30 minutes to ...
CT Insider on MSN50m
Stamford-based drug developer for rare cancers and tumors sold for $3.9 billion to German company
A German-based company is buying SpringWorks Therapeutics for $3.9 billion years after the local company developed a drug to treat rare tumors and is expanding to tackle varying forms of cancer.